We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Computer Model Helps Explain Why Some Proteins Misfold

By LabMedica International staff writers
Posted on 09 May 2011
A computer model that emulates the conditions that exist inside the cellular endoplasmic reticulum has provided information regarding the factors that cause proteins to misfold and aggregate, characteristics of diseases such as Alzheimer's disease and diabetes.

Investigators at the University of Michigan (Ann Arbor, USA) used a continuous flow reactor model of the endoplasmic reticulum to study proteins that misfold and their interaction with "bystander” proteins that somehow contribute to the process that lead to misfolding. More...
This process often displays a threshold behavior characterized by a sudden shift between nontoxic to toxic levels of misfolded proteins.

They reported in the April 20, 2011 issue of Biophysical Journal that slight changes in the bystander protein-residence time in the endoplasmic reticulum or the ratio of basal misfolded to bystander protein inflow rates can trigger the threshold behavior in protein misfolding.

"There are many diseases, including cystic fibrosis, Alzheimer's disease, Huntington's disease, Parkinson's disease, and diabetes that are products of improperly folded - but potentially functional - proteins,” said senior author Dr. Santiago Schnell, associate professor of molecular and integrative physiology at the University of Michigan. "These diseases are known as protein folding or conformational diseases.”

"Our model proposes a couple of remedies for recovering a patient's own misfolded proteins so they become correctly folded and functional proteins again,” said Dr. Schnell.

"The first remedy is giving the patient a higher concentration of correctly folded proteins to increase the ratio of folded over misfolded proteins. An improved ratio will prevent attack by misfolded proteins. The second remedy is administering drugs to patients to help the proteins fold correctly and to accelerate the folding of proteins, which reduces the chances of misfolding during protein synthesis.”

Related Links:

University of Michigan



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.